 Kejun Guo
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 6 | 2022 | 771 | 0.930 |
Why?
| | Friend murine leukemia virus | 7 | 2021 | 30 | 0.890 |
Why?
| | Cytidine Deaminase | 8 | 2018 | 57 | 0.880 |
Why?
| | Retroviridae Infections | 7 | 2021 | 45 | 0.870 |
Why?
| | Dendritic Cells | 3 | 2020 | 438 | 0.790 |
Why?
| | Interferon-alpha | 2 | 2020 | 186 | 0.780 |
Why?
| | Gastrointestinal Tract | 2 | 2020 | 168 | 0.740 |
Why?
| | Interferon-beta | 1 | 2020 | 79 | 0.710 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 2 | 2015 | 17 | 0.620 |
Why?
| | Antiviral Agents | 3 | 2020 | 649 | 0.590 |
Why?
| | HIV Infections | 6 | 2022 | 2474 | 0.550 |
Why?
| | Immunoglobulin Variable Region | 1 | 2015 | 72 | 0.500 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 72 | 0.490 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 69 | 0.480 |
Why?
| | B-Lymphocytes | 2 | 2015 | 773 | 0.370 |
Why?
| | Antibodies, Neutralizing | 4 | 2021 | 222 | 0.350 |
Why?
| | Virus Replication | 6 | 2017 | 396 | 0.330 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2022 | 965 | 0.290 |
Why?
| | Antibodies, Viral | 4 | 2022 | 527 | 0.280 |
Why?
| | Adaptive Immunity | 2 | 2021 | 157 | 0.280 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2021 | 4 | 0.200 |
Why?
| | Membrane Glycoproteins | 2 | 2016 | 431 | 0.200 |
Why?
| | Antigens, CD | 2 | 2016 | 442 | 0.190 |
Why?
| | Specimen Handling | 1 | 2022 | 156 | 0.180 |
Why?
| | Proteins | 2 | 2018 | 920 | 0.180 |
Why?
| | Keratinocytes | 2 | 2018 | 215 | 0.160 |
Why?
| | Dysbiosis | 2 | 2022 | 146 | 0.160 |
Why?
| | Immunoglobulin M | 2 | 2022 | 254 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1537 | 0.160 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 9 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 826 | 0.150 |
Why?
| | Cullin Proteins | 1 | 2018 | 12 | 0.150 |
Why?
| | Human papillomavirus 16 | 1 | 2018 | 25 | 0.150 |
Why?
| | Viral Tropism | 1 | 2017 | 24 | 0.150 |
Why?
| | Proteolysis | 1 | 2018 | 145 | 0.150 |
Why?
| | Enterobacteriaceae | 1 | 2017 | 33 | 0.140 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2017 | 129 | 0.140 |
Why?
| | Interferon Type I | 1 | 2017 | 129 | 0.130 |
Why?
| | Immunoglobulin G | 2 | 2022 | 781 | 0.130 |
Why?
| | Antibody Diversity | 1 | 2015 | 16 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 503 | 0.130 |
Why?
| | Virion | 2 | 2015 | 74 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2015 | 732 | 0.130 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 84 | 0.120 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2015 | 71 | 0.120 |
Why?
| | Macaca mulatta | 1 | 2015 | 132 | 0.120 |
Why?
| | Leukemia, Experimental | 1 | 2014 | 27 | 0.120 |
Why?
| | Papillomavirus Infections | 1 | 2018 | 258 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 342 | 0.120 |
Why?
| | Tumor Virus Infections | 1 | 2014 | 41 | 0.120 |
Why?
| | Base Sequence | 2 | 2015 | 2114 | 0.120 |
Why?
| | Papillomaviridae | 1 | 2014 | 100 | 0.120 |
Why?
| | Gene Frequency | 1 | 2015 | 485 | 0.110 |
Why?
| | Viral Load | 4 | 2021 | 405 | 0.110 |
Why?
| | Intestines | 1 | 2017 | 324 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3037 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2021 | 2604 | 0.110 |
Why?
| | Endoribonucleases | 1 | 2013 | 62 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 443 | 0.100 |
Why?
| | Endogenous Retroviruses | 1 | 2012 | 19 | 0.100 |
Why?
| | Animals | 11 | 2021 | 32104 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2016 | 528 | 0.090 |
Why?
| | Antibody Formation | 1 | 2011 | 273 | 0.090 |
Why?
| | Genetic Variation | 1 | 2015 | 880 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1168 | 0.080 |
Why?
| | Interleukin-2 | 2 | 2022 | 417 | 0.070 |
Why?
| | Reverse Transcription | 2 | 2021 | 19 | 0.070 |
Why?
| | Young Adult | 2 | 2020 | 10518 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2013 | 731 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4773 | 0.070 |
Why?
| | Mice | 7 | 2021 | 15052 | 0.070 |
Why?
| | Middle Aged | 3 | 2020 | 27069 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 1919 | 0.060 |
Why?
| | Signal Transduction | 1 | 2017 | 4541 | 0.060 |
Why?
| | Adult | 3 | 2020 | 30789 | 0.060 |
Why?
| | Humans | 10 | 2022 | 115741 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2017 | 3914 | 0.060 |
Why?
| | Female | 5 | 2021 | 60018 | 0.050 |
Why?
| | Male | 4 | 2021 | 56050 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 40 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 106 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 94 | 0.050 |
Why?
| | Antigen Presentation | 1 | 2021 | 189 | 0.050 |
Why?
| | RNA, Viral | 2 | 2016 | 565 | 0.040 |
Why?
| | Colon | 1 | 2022 | 234 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 351 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 2013 | 3580 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 73 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 133 | 0.040 |
Why?
| | Palatine Tonsil | 1 | 2017 | 32 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2017 | 22 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 104 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 693 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2016 | 54 | 0.030 |
Why?
| | Phenotype | 2 | 2016 | 2839 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2016 | 137 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2016 | 76 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 729 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 602 | 0.030 |
Why?
| | APOBEC-1 Deaminase | 1 | 2014 | 5 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 268 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 423 | 0.030 |
Why?
| | Cervix Uteri | 1 | 2014 | 44 | 0.030 |
Why?
| | Germinal Center | 1 | 2014 | 49 | 0.030 |
Why?
| | Viremia | 1 | 2014 | 122 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1083 | 0.030 |
Why?
| | Acute Disease | 1 | 2016 | 914 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 383 | 0.030 |
Why?
| | Spleen | 1 | 2014 | 492 | 0.030 |
Why?
| | Inbreeding | 1 | 2012 | 16 | 0.030 |
Why?
| | Immunity, Humoral | 1 | 2013 | 112 | 0.030 |
Why?
| | NF-kappa B | 1 | 2016 | 639 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2016 | 1057 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 736 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 399 | 0.020 |
Why?
| | Plasma | 1 | 2011 | 213 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2790 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2011 | 391 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1122 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 4448 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2353 | 0.020 |
Why?
| | Mutation | 1 | 2014 | 3364 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19294 | 0.010 |
Why?
| | Child | 1 | 2017 | 18503 | 0.010 |
Why?
|
|
Guo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|